









Markets
/
Stocks
/
nasdaq-dmaa
/

Drugs Made In America Acquisition Corp

DMAA

10.380USD

+0.020+0.19%

Market hours （ET）Quotes delayed by 15 min

347.89MMarket Cap

94.62P/E TTM



Drugs Made In America Acquisition Corp

10.380

+0.020+0.19%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can find the annual or quarterly income statement of Drugs Made In America Acquisition Corp here for insights into the performance and operational efficiency of Drugs Made In America Acquisition Corp.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

Operating expenses

--263.70K

--131.92K

--330.93K

Operating profit

---263.70K

---131.92K

---330.93K

Net non-operating interest income (expenses)

Non-operating interest income

--2.45M

--2.42M

--1.59M

Income before tax

--2.18M

--2.29M

--1.25M

Income after tax

--2.18M

--2.29M

--1.25M

Net income from continuous operations

--2.18M

--2.29M

--1.25M

Net income attributable to controlling interests

--2.18M

--2.29M

--1.25M

Net income attributable to common shareholders

--2.18M

--2.29M

--1.25M

Basic earnings per share

--0.07

--0.08

Diluted earnings per share

--0.07

--0.08

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

